FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...

Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

A New York Times report updates some of the behind-the-scenes thinking at FDA and other federal agencies; ‘defined,’ not ...

The following is the transcript of an interview with FDA commissioner Dr. Marty Makary that aired on "Face the Nation with ...

The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce ...

FDA Commissioner Dr. Marty Makary discusses vaccine safety for children, baby formula nutrition and more on ‘The Brian ...

A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing ...

The FDA has launched a pilot program using generative AI to help expedite the review of drug and device applications, part of a sweeping modernization effort by the agency. The initiative, led by FDA ...

Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...

Dr. Marty Makary, the Johns Hopkins surgeon and professor whom President Donald Trump tapped to lead the U.S. Food and Drug ...

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...